Procter And Gamble
- All
- News
- Videos
-
Procter & Gamble To Set Up Rs 2,000 Crore Manufacturing Unit In India
Procter & Gamble India said it would invest 20 billion rupees ($243.79 million) to set up a personal healthcare manufacturing facility in the western state of Gujarat.
-
CES 2022: AMD, P&G Join Google and Others in Opting Out of Event Over Omicron Fears
AMD, Procter & Gamble, and Micro-Star International are among the latest companies to pull out of the CES event —taking place in-person in Las Vegas in January 2022 — over Omicron fears.
-
Procter & Gamble Health Sheds Over 6% After Profit Drops 66% In March Quarter
Procter & Gamble Health Share Price: On Friday, Procter and Gamble Health opened on the BSE at Rs 6,040, witnessing an intra day high of Rs 6,040, and an intra day low of Rs 5,700, so far.
-
Unilever Plans $3.6 Billion Buyback As China And Home Cooks Boost Growth
Shares in the maker of Dove soap and Ben and Jerry's ice cream climbed as much as four per cent on Thursday, after it joined rivals such as Nestle and Procter & Gamble in reporting strong sales of food and cleaning products respectively in the pandemic.
-
"Is This The Best A Man Can Get?" Gillette's #MeToo Rebrand Sparks Debate
#MeToo Movement: An individual. Acquisitive. Assertive. And always clean-shaven. This was the vision of masculinity depicted in a Gillette ad campaign that debuted in January 1989 during Super Bowl XXIII.
-
Amazon's Prime Day Evolves From Rummage Sale to Must-Shop Event
Many brands decided it's smarter to offer steep discounts and pay Amazon for advertising to win sales on the site than to sit out an event estimated to generate $3.4 billion in spending.
-
P&G Profit, Sales Beat Wall Street Estimates
Cincinnati, Ohio-based P&G said its core earnings per share, which excludes restructuring charges and other items, was $1.08, in the second quarter ended December 31.
-
Unilever Sharpens P&G Rivalry By Buying Dollar Shave Club
Unilever Plc is to buy U.S.-based Dollar Shave Club, expanding its presence in the growing market for male grooming products and sharpening its rivalry with Procter & Gamble which owns the Gillette brand.
-
Court Reserves Verdict On Pleas Against Ban On 344 Drugs
The Delhi High Court on Thursday reserved its verdict in over 450 petitions filed by drug and healthcare majors challenging the Centre's decision to ban 344 fixed dose combination (FDC) medicines, including well-known brands like Corex cough syrup, Vicks Action 500 extra and D'Cold.
-
P&G March Quarter Profit Rises 12% To Rs 97 Crore
FMCG firm Procter and Gamble Hygiene and Health Care (P&G) on Thursday reported a 11.98 per cent increase in standalone net profit to Rs 97.30 crore for the third quarter ended March 31.
-
Wall Street Pares Gains As 3M, Procter & Gamble Weigh
Wall Street pared early gains and was little changed in late morning trading on Tuesday, weighed down by quarterly results of Dow components 3M and Procter & Gamble.
-
High Court To Resume Hearing On Petitions Against Centre's Ban On Drugs
Delhi High Court is likely to resume today the hearing on petitions by over 30 pharmaceutical majors, including Pfizer, Glenmark, Procter and Gamble (P&G) and Cipla, challenging the government's decision to ban sale of some of their fixed dose combination medicines.
-
P&G to Resume Vicks Action 500 Extra Manufacturing, Sale
FMCG firm Procter and Gamble (P&G) on Wednesday said it will resume manufacturing and sale of its popular brand 'Vicks Action 500 Extra' after the Delhi High Court stayed government's order banning fixed dose combination drugs.
-
Procter & Gamble Stops Selling Vicks Action 500 Extra in India After Ban
U.S. consumer health giant Procter & Gamble's India unit said on Tuesday it had stopped manufacture and sale of its cough-and-cold medicine Vicks Action 500 Extra with immediate effect, after regulators banned it citing potential health risk.
-
P&G Net Up 62% to Rs 147 Crore in Q2
FMCG major Procter and Gamble Hygiene and Health Care Ltd (P&G) on Saturday reported a 61.81 per cent jump in the net profit to Rs 146.7 crore for the second quarter ended December 31.
-
Procter & Gamble To Set Up Rs 2,000 Crore Manufacturing Unit In India
Procter & Gamble India said it would invest 20 billion rupees ($243.79 million) to set up a personal healthcare manufacturing facility in the western state of Gujarat.
-
CES 2022: AMD, P&G Join Google and Others in Opting Out of Event Over Omicron Fears
AMD, Procter & Gamble, and Micro-Star International are among the latest companies to pull out of the CES event —taking place in-person in Las Vegas in January 2022 — over Omicron fears.
-
Procter & Gamble Health Sheds Over 6% After Profit Drops 66% In March Quarter
Procter & Gamble Health Share Price: On Friday, Procter and Gamble Health opened on the BSE at Rs 6,040, witnessing an intra day high of Rs 6,040, and an intra day low of Rs 5,700, so far.
-
Unilever Plans $3.6 Billion Buyback As China And Home Cooks Boost Growth
Shares in the maker of Dove soap and Ben and Jerry's ice cream climbed as much as four per cent on Thursday, after it joined rivals such as Nestle and Procter & Gamble in reporting strong sales of food and cleaning products respectively in the pandemic.
-
"Is This The Best A Man Can Get?" Gillette's #MeToo Rebrand Sparks Debate
#MeToo Movement: An individual. Acquisitive. Assertive. And always clean-shaven. This was the vision of masculinity depicted in a Gillette ad campaign that debuted in January 1989 during Super Bowl XXIII.
-
Amazon's Prime Day Evolves From Rummage Sale to Must-Shop Event
Many brands decided it's smarter to offer steep discounts and pay Amazon for advertising to win sales on the site than to sit out an event estimated to generate $3.4 billion in spending.
-
P&G Profit, Sales Beat Wall Street Estimates
Cincinnati, Ohio-based P&G said its core earnings per share, which excludes restructuring charges and other items, was $1.08, in the second quarter ended December 31.
-
Unilever Sharpens P&G Rivalry By Buying Dollar Shave Club
Unilever Plc is to buy U.S.-based Dollar Shave Club, expanding its presence in the growing market for male grooming products and sharpening its rivalry with Procter & Gamble which owns the Gillette brand.
-
Court Reserves Verdict On Pleas Against Ban On 344 Drugs
The Delhi High Court on Thursday reserved its verdict in over 450 petitions filed by drug and healthcare majors challenging the Centre's decision to ban 344 fixed dose combination (FDC) medicines, including well-known brands like Corex cough syrup, Vicks Action 500 extra and D'Cold.
-
P&G March Quarter Profit Rises 12% To Rs 97 Crore
FMCG firm Procter and Gamble Hygiene and Health Care (P&G) on Thursday reported a 11.98 per cent increase in standalone net profit to Rs 97.30 crore for the third quarter ended March 31.
-
Wall Street Pares Gains As 3M, Procter & Gamble Weigh
Wall Street pared early gains and was little changed in late morning trading on Tuesday, weighed down by quarterly results of Dow components 3M and Procter & Gamble.
-
High Court To Resume Hearing On Petitions Against Centre's Ban On Drugs
Delhi High Court is likely to resume today the hearing on petitions by over 30 pharmaceutical majors, including Pfizer, Glenmark, Procter and Gamble (P&G) and Cipla, challenging the government's decision to ban sale of some of their fixed dose combination medicines.
-
P&G to Resume Vicks Action 500 Extra Manufacturing, Sale
FMCG firm Procter and Gamble (P&G) on Wednesday said it will resume manufacturing and sale of its popular brand 'Vicks Action 500 Extra' after the Delhi High Court stayed government's order banning fixed dose combination drugs.
-
Procter & Gamble Stops Selling Vicks Action 500 Extra in India After Ban
U.S. consumer health giant Procter & Gamble's India unit said on Tuesday it had stopped manufacture and sale of its cough-and-cold medicine Vicks Action 500 Extra with immediate effect, after regulators banned it citing potential health risk.
-
P&G Net Up 62% to Rs 147 Crore in Q2
FMCG major Procter and Gamble Hygiene and Health Care Ltd (P&G) on Saturday reported a 61.81 per cent jump in the net profit to Rs 146.7 crore for the second quarter ended December 31.
